论文部分内容阅读
我国药品数据保护政策的实施将会延长创新药品的市场专属权,从而提高药品价格并降低基本药品的可及性。本文旨在研究仿制药替代对我国的作用,量化数据保护对我国药品费用和药品可及性的影响。研究结果显示,数据保护的实施将增加45.55%药品费用,并使药品可及性降低27.14%,对我国药品产业有较大的负面影响。因此,数据保护在我国的全面实施仍为时尚早。
The implementation of China’s drug data protection policy will prolong the market exclusiveness of innovative medicines, thereby increasing drug prices and reducing the availability of essential medicines. The purpose of this paper is to study the effect of generic drug substitution on our country, and to quantify the impact of data protection on drug costs and drug availability in China. The results show that the implementation of data protection will increase the cost of 45.55% of drugs and reduce the availability of drugs by 27.14%, which will have a significant negative impact on the pharmaceutical industry in China. Therefore, the full implementation of data protection in our country is still too early.